Preview

Rational Pharmacotherapy in Cardiology

Advanced search

DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION?

https://doi.org/10.20996/1819-6446-2013-9-6-619-626

Full Text:

Abstract

Concept of deterioration of myocardial contractile function under long-term intake of antiarrhythmic drugs may be regarded as one of the myths of modern cardiology. Multiple references to negative influence of majority of antiarrhythmic drugs on myocardial inotropic function are speculative. Studies on estimation of influence of arrhythmia treatment strategy on myocardial contractile function are almost absent.
Aim. To estimate dynamics of myocardial contractile function in patients with ischemic heart disease (IHD) and persistent atrial fibrillation (AF) compared among those treated with amiodarone 200 mg daily and with bisoprolol 5 mg daily.
Material and methods. A total of 47 IHD patients with persistent AF were enrolled into the study. Sinus rhythm (SR) was restored during the first 24 hours of hospitalization in all the pa- tients. After SR restoration the patients were randomly allocated to two groups receiving either amiodarone 200 mg daily during 6 months for SR maintenance (group 1) or bisoprolol 5 mg daily for ventricular rate (VR) control (group 2). To estimate myocardial inotropic function all patients underwent steady-state radionuclide ventriculography (RVG) and echocardiography during the first 24 hours after SR restoration and 6 months later.
Results. We revealed changes in left ventricle (LV) diastolic function, reduction of left atrium (LA) contribution to LV diastole and enlargement of LA anterior-posterior dimension during the first 24 hours after SR restoration in the patients of both groups.
6-month SR maintenance in the first group of patients promoted significant decrease in isovolumic relaxation time (IVRT) from 103.4±1.01 ms to 96.4±1.1ms (р=0.02) and reduction of LA anterior-posterior dimension up to 36.1±3.8 mm (р=0.03). Target VR achievement in the second group of patients promoted restoration of LV diastolic function (decrease in IVRT from
104.3±1.2 ms to 97.3±1.2 ms; р=0.03) but did not influence LA size (44.1±3.1 mm and 43.5±3.0 mm, respectively). Atrial inotropic function was only changed in the patients of group 1, the patients of group 2 did not reveal significant change in LA contribution to LV diastole.
Conclusion. 6-month SR maintenance at amiodarone intake in IHD patients with persistent AF resulted in LA contraction, restoration of its contractility and improvement of LV diastolic parameters. Target VR for 6 months of bisoprolol intake led to LV diastolic function improvement, but did not influence LA dimension and contractile function.

About the Authors

V. I. Podzolkov
I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Ph.D., MD, Professor, Head of Faculty Therapy Chair №2, Medical Faculty of the I.M. Sechenov First State Moscow Medical University


A. I. Tarzimanova
I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
Ph.D., MD, Docent of the same chair


I. J. Loriya
I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
MD, Ph.D. candidate of the same chair


L. N. Mokhammadi
I.M. Sechenov First Moscow State Medical University, Moscow
Russian Federation
MD, Ph.D. candidate of the same chair


References

1. Camm A. J. Atrial fibrillation and risk. ClinCardiol 2012; 35 Suppl 1: 1-2.

2. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31(19):2369-429.

3. AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.

4. Van Gelder IC, Hagens VE, Bosker HA et all. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.

5. Carlsson J, Miketic S, Windeler J and the STAF Investigators. Randomized trial of rate-control versus rhythm- control in persistent atrial fibrillation. J Am CollCardiol 2003;41:1690-6.

6. Opolski G, Torbicki A, Kosior DA Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004;126:476-86.

7. Roy D, Talajic M, Nattel S, et all. Rhythm control versus rate control for atrial fibrillation and heart fail- ure. N Engl J Med 2008;358:2667-77.

8. Hohnloser SH, Kuck KH, Lilienthal Jet all. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000;356:1789-94.

9. Camm A. J., Savelieva I. Atrial fibrillation: the rate versus rhythm management controversy. J R Coll Physicians Edinb 2012; 42 Suppl 18: 23-34.

10. Boldt A, Wetzel U, Weigl J, et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 2003;42:1785-92.

11. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000;101:2678-81.

12. Oudot A, Vergely C, Ecarnot-Laubriet A, et al. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. Eur J Pharmacol 2003;462:145-54

13. Gronefeld GC, Hohnloser SH. Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications. J Cardiovasc Pharmacol Ther 2003; 8(2): 107-13.

14. Caldeira D, David C, Sampaio C. Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials. Arch Cardiovasc Dis 2012;105: 226-38.


For citation:


Podzolkov V.I., Tarzimanova A.I., Loriya I.J., Mokhammadi L.N. DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Rational Pharmacotherapy in Cardiology. 2013;9(6):619-626. https://doi.org/10.20996/1819-6446-2013-9-6-619-626

Views: 592


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)